Breast Cancer Research And Treatment

雜志介紹

Breast Cancer Research And Treatment雜志介紹

《Breast Cancer Research And Treatment》是一本以English為主的未開放獲取國際優秀期刊，中文名稱乳腺癌研究和治療，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3，最新CiteScore 指數為6.8。

本刊近期中國學者發表的論文主要有：

• Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial

  Author: Xie, Xiao-Feng; Zhang, Qiu-Yi; Huang, Jia-Yi; Chen, Li-Ping; Lan, Xiao-Feng; Bai, Xue; Song, Lin; Xiong, Shui-Ling; Guo, Si-Jia; Du, Cai-Wen

• Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis

  Author: Cao Lu; Yang Yang; Li Lingmei; Huang Qiujuan; Guo Qianru; Qi Lisha; Cao Wenfeng; Niu Yun; Zhang Peisen

• Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population

  Author: Chen, Ruixian; Qi, Yana; Huang, Ya; Liu, Weijing; Yang, Ruoning; Zhao, Xin; Wu, Yunhao; Li, Qintong; Wang, Zhu; Sun, Xin; Wei, Bing; Chen, Jie

• Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis

  Author: Yang, Zhengyan; Xu, Hongyun; Yang, Yupo; Duan, Chaoqun; Zhang, Pai; Wang, Yang; Fu, Kai; Shen, Yonghong; Xu, Marvin Xuejun

英文介紹

Breast Cancer Research And Treatment雜志英文介紹

Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.